Effects of Rosiglitazone and Pioglitazone Combined with Metformin on the Prothrombotic State of Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

Author： Derosa G   D'Angelo A   Ragonesi PD   Ciccarelli L   Piccinni MN   Pricolo F   Salvadeo S   Montagna L   Gravina A   Ferrari I   Galli S   Paniga S   Cicero AFG  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.34, Iss.5, 2006-09, pp. : 545-555

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A fixed combination of rosiglitazone plus metformin improves glycaemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus (T2DM)

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK

By Home Philip  

PharmacoEconomics, Vol. 25, Iss. 9, 2007-01 ,pp. : 801-802

Adis International

Access to resources Recommend Favorite

A Lifetime Modelled Economic Evaluation Comparing Pioglitazone and Rosiglitazone for the Treatment of Type 2 Diabetes Mellitus in the UK

By Tilden Dominic P.  

PharmacoEconomics, Vol. 25, Iss. 1, 2007-01 ,pp. : 39-54

Adis International

Access to resources Recommend Favorite

Retrospective Analysis of Rosiglitazone and Macular Oedema in Patients with Type 2 Diabetes Mellitus

By Tatti Patrizio  

Clinical Drug Investigation, Vol. 28, Iss. 5, 2008-01 ,pp. : 327-332

Adis International

Access to resources Recommend Favorite

Pioglitazone is Effective Therapy for Elderly Patients with Type 2 Diabetes Mellitus

By Rajagopalan R.   Perez A.   Ye Z.   Khan M.   Murray F.T.  

Drugs & Aging, Vol. 21, Iss. 4, 2004-01 ,pp. : 259-271

Adis International

Access to resources Recommend Favorite